<DOC>
	<DOCNO>NCT01088009</DOCNO>
	<brief_summary>The purpose study compare adefovir early add-on rescue therapy strategy , also explore efficacy Lamivudine adefovir de-novo combination therapy .</brief_summary>
	<brief_title>Efficacy Optimizing Research Lamivudine Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<criteria>Male female age 1865 year ; Capable understand signing informed consent . Willing comply study requirement ; Serum HBsAg HBeAg positive study screening ; Documented chronic hepatitis B infection determine presence serum HBsAg least 6 month ; History decompensated liver function , current signs/symptoms decompensation e.g . ascites , variceal bleeding , encephalopathy spontaneous peritonitis ; protocol define inclusion/exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>chronic hepatitis B</keyword>
</DOC>